Benzotriazole ultraviolet stabilizers
(BUVSs) are high-production-volume
chemicals with ubiquitous occurrence in the aquatic environment. However,
little is known about their bioconcentration and biotransformation,
and physiologically based toxicokinetic (PBTK) models for BUVSs are
lacking. This study selected six BUVSs for which experiments were
performed with zebrafish (Danio rerio) exposed to two different levels (0.5 and 10 μg·L–1). Higher kinetic bioconcentration factors (BCFs)
were observed at the lower exposure level with environmental relevance,
with BCF of 3.33 × 103 L·kg–1 for 2-(2-hydroxy-3,5-di-tert-butylphenyl)-5-chlorobenzotriazole
(UV-327). This phenomenon was interpreted by a nonlinear adsorption
mechanism, where binding with specific protein sites contributes to
bioconcentration. Muscle exhibited the lowest accumulation, in which
depuration half-life of UV-327 was 19.5 d. In kidney, muscle, ovary,
gill, and skin, logBCF increased with increase in log K
OW of the BUVSs until log K
OW was ca. 6.5, above which logBCF decreased. However, the
trend was not observed in the liver and intestine. Six biotransformation
products were identified and mainly accumulated in the liver and intestine.
Considering the nonlinear adsorption mechanism in the PBTK model,
the prediction accuracy of the model was improved, highlighting the
binding of xenobiotics with specific protein sites in assessing the
bioconcentration of chemicals for their risk assessment.